Response to Tocilizumab in Rheumatoid Arthritis Is Not Influenced by the Body Mass Index of the Patient
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Response to Tocilizumab in Rheumatoid Arthritis Is Not Influenced by the Body Mass Index of the Patient |
| Type de publication | Journal Article |
| Year of Publication | 2015 |
| Auteurs | Pers Y-M, Godfrin-Valnet M, Lambert J, Fortunet C, Constant E, Mura T, Pallot-Prades B, Jorgensen C, Maillefert J-F, Marotte H, Wendling D, Gaudin P |
| Journal | JOURNAL OF RHEUMATOLOGY |
| Volume | 42 |
| Pagination | 580-584 |
| Date Published | APR |
| Type of Article | Article |
| ISSN | 0315-162X |
| Mots-clés | body mass index, Response, Rheumatoid arthritis, tocilizumab |
| Résumé | {Objective. To assess the relationship between the body mass index (BMI) and the efficacy of tocilizumab (TCZ) in patients with rheumatoid arthritis (RA). Methods. We conducted a retrospective study in 222 patients with RA followed by 5 centers. The European League Against Rheumatism response was evaluated at 6 months. Univariate and multivariate logistic regressions were performed. Results. No significant association between the BMI and the response to TCZ at 6 months was found after adjustment for potential confounding factors (adjusted OR 0.45, 95% CI 0.16-1.24 |
| DOI | 10.3899/jrheum.140673 |